Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Beyond Air, Inc. (XAIR) Reports In-Line Q1 EPS, Revenues Beat
November 11, 2020 4:32 PM ESTBeyond Air, Inc. (NASDAQ: XAIR) reported Q1 EPS of ($0.30), in-line with the analyst estimate of ($0.30). Revenue for the quarter came in at $349.6 thousand versus the consensus estimate of $120 thousand.
Over the past few months we have achieved several significant milestones, both regulatory and clinical, across our development pipeline. Most notably, we filed a PMA for the LungFit PH system for the treatment of PPHN, which will be subject to the standard 180-day FDA... More
